The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - MSD
Consulting or Advisory Role - Kyowa Hakko Kirin; Novartis; Ono Pharmaceutical
Speakers' Bureau - BL Pharma; Bristol-Myers Squibb; Chugai Pharma; Lilly; Ono Pharmaceutical
Research Funding - AstraZeneca; Bristol-Myers Squibb; Ono Pharmaceutical
VOLTAGE: Multicenter phase 1b/II study of nivolumab monotherapy and subsequent radical surgery after preoperative chemoradiotherapy with capecitabine in patients with locally advanced rectal cancer.
 
Yuichiro Tsukada
No Relationships to Disclose
 
Hideaki Bando
Research Funding - AstraZeneca; Sysmex
 
Koji Inamori
No Relationships to Disclose
 
Shota Fukuoka
No Relationships to Disclose
 
Takeshi Sasaki
No Relationships to Disclose
 
Yuji Nishizawa
No Relationships to Disclose
 
Daisuke Kotani
No Relationships to Disclose
 
Motohiro Kojima
No Relationships to Disclose
 
Yosuke Togashi
No Relationships to Disclose
 
Naoki Nakamura
No Relationships to Disclose
 
Tetsuo Akimoto
No Relationships to Disclose
 
Yoshito Komatsu
Honoraria - Bayer; Novartis; Pfizer
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Bayer; Chugai Pharma; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Satoshi Yuki
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda
 
Shigenori Homma
No Relationships to Disclose
 
Yutaka Hatanaka
Honoraria - AstraZeneca; Ono Pharmaceutical
Consulting or Advisory Role - GeneticLab; Medicinal Chemistry Pharmaceutical
Speakers' Bureau - Chugai Pharma; Merck Sharp & Dohme; Pfizer
Research Funding - Eisai; Merck Sharp & Dohme; Roche; Taiho Pharmaceutical
 
Yoshihiro Matsuno
No Relationships to Disclose
 
Akihiro Sato
Honoraria - AstraZeneca; Dainippon Sumitomo Pharma
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Hiroyoshi Nishikawa
Speakers' Bureau - Bristol-Myers Squibb; Ono Pharmaceutical
Research Funding - Bristol-Myers Squibb; Daiichi Sankyo; Kyowa Hakko Kirin; Ono Pharmaceutical; Sysmex; Taiho Pharmaceutical; Zenyaku Kogyo
 
Masaaki Ito
Stock and Other Ownership Interests - A-Traction
Honoraria - Ethicon
Research Funding - ConMed; Niti-On; Ono Pharmaceutical; Yakult Pharmaceutical
 
Takayuki Yoshino
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline K.K. (Inst)